At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 251 enrolled
Drug / intervention
Tramadoldrug
Likely dose
Tramadol 50 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety of Tramadol Infusion (AVE-901) in the Management of Post-Operative Pain Following Surgery
In Brief
A Phase 3 clinical trial evaluating Tramadol for Pain Management. Completed, enrolled 251 participants across 1 site.
Detailed Summary
The study evaluates the safety of IV tramadol managing post-operative pain following surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
Enrollment StartDec 2017
First PostedJan 2018
Primary CompletionApr 2019
Study CompletionMay 2019
TodayJul 2026
First PostedJan 10, 2018
Enrollment StartDec 22, 2017
Primary CompletionApr 25, 2019
Study CompletionMay 6, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.5 years ago
Interventions
Tramadoldrug
IV; 50 mg given at Hours 0, 2, 4, 8 and every 4 hours thereafter, for a total of up to 43 doses